SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 52.51+2.7%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (4490)8/17/2001 1:13:20 PM
From: Biomaven  Read Replies (1) of 52153
 
Two snippets related only by an "Aaargh!":

Vical's experimental gene-based immunotherapy for metastatic melanoma, during an upcoming episode of the ``Healthy Solutions'' television series scheduled to air as paid programming on CNBC

And in a quite different Aaargh! category, this quote from TSC:

Analog Devices' CEO put an interesting spin on its backlog stabilizing, stating that "There's not much left there to cancel."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News